Anatomic Pathology Market size is projected to cross USD 59424 million by the end of 2033, growing at a CAGR of 9% during the forecast period, i.e., 2023-2033. In the year 2022, the industry size of anatomic pathology was USD 24337 million. The growth of the market can primarily be attributed to the growing number of laboratory tests worldwide. For instance, every year over 7 billion clinical lab tests are performed in the United States.
Anatomic (or anatomical) pathology being the branch of medicine studies the effects of particular disease on the structure of body organs and tissues. Anatomic pathology identifies abnormalities and help to diagnose disease and manage treatment. Most of the anatomic pathology is to help identify and manage various types of tumors or cancers, but it is also helps to evaluate other conditions. With the recent advancements digital pathology as well as Artificial Intelligence (AI), the demand for anatomic pathology is on the rise amongst the healthcare service providers, which in turn, is expected to create massive revenue generation opportunities for the key players operating in the global anatomic pathology market during the forecast period. For instance, as per a survey conducted on the integration of artificial intelligence into diagnostic pathology practice, out of 487 respondents, ~80 percent expected the integration in the upcoming 5 or 10 years, whereas ~70% predicted that AI tools could increase diagnostic efficiency in future.
Growth Drivers
Growing Cancer Cases – Cancer cases are detected through anatomic pathology report. With the rising cases of cancer and need for biopsies to be performed, the market for anatomic pathology is expected to boost in the projected period. For instance, it was observed that approximately 19 million new cancer cases were registered worldwide in 2020.
Upsurge in the Number of Pathologists – According to reports, it was found that, in the United States there were ~21 292 active pathologists in June 2019 compared ~12 839 anatomical and clinical pathologists in 2017.
Challenges
|
Base Year |
2022 |
|
Forecast Year |
2023-2033 |
|
CAGR |
~9% |
|
Base Year Market Size (2022) |
~USD 24337 Million |
|
Forecast Year Market Size (2033) |
~USD 59424 Million |
Type (Services, Consumables, Instruments); Subdivision (Histopathology, Cytopathology)
The global anatomic pathology market is segmented and analyzed for demand and supply by type into services, consumables, and instruments. Amongst these segments, the services segment – 48.12% held the largest share in 2022, backed by the growing number of breast cancers along with the surge in the number of biopsies done worldwide. For instance, over 17 720 biopsies were recommended and performed, in between January 2019 to September 2020 in the United States.
Major Macro-Economic Indicators Impacting the Market Growth
According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.
Our in-depth analysis of the global market includes the following segments:
|
By Type |
|
|
By Subdivision |
|
|
By Product Type |
|
|
By Application |
|
|
By End-User |
|
Regionally, the global anatomic pathology market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in North America held the largest market share of 39.21% in 2022, backed by the presence of a strong healthcare network in the region, growing number of hospitals and diagnostic centers, as well as the rising demand for advanced anatomic pathology amongst the healthcare service providers owing to the rising number of surgeries in the region. For instance, it was observed that, ~15 million Europeans have surgery every year. Some of the most common surgeries performed are appendectomy, breast biopsy, carotid endarterectomy, cholecystectomy, coronary artery bypass and others.
Epredia, - a subsidiary of PHC Holdings Corporation announced that its parent company has acquired anatomical pathology suppliers Laurypath and Microm Microtech France (MMFrance) to mark strategic expansion of Epredia’s presence in Europe.
Indica Labs, Inc., - with The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics(iCAIRD), announced an agreement to collaborate on the development of an AI-based digital pathology solution. The pathology will assist the detection of cancer within lymph nodes from colorectal surgery cases.
Author Credits: Radhika Gupta, Shivam Bhutani
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?